[Limits and possibilities of neoplasm immunotherapy].
Immunological treatment of malignant human tumors has so far met with little success. Based on methods and insights obtained by investigation of corresponding animal models, this article attempts to elucidate the reasons for this failure and to suggest ways and means to improve immunotherapeutic approaches to human neoplasms.
D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000145:classification; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002454:Cell Differentiation; D003429:Cross Reactions; D004622:Embryo, Mammalian / Q000276:immunology; D000939:Epitopes; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009858:Oncogenic Viruses / Q000276:immunology; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D000939:Epitopes; D000509:alpha-Fetoproteins
Grenzen und Möglichkeiten der Immuntherapie von Tumoren.